Developing new treatments for Hodgkin lymphoma and related cancers
Official title: Leading NCI Clinical Trials Network research nationally and at the City of Hope Comprehensive Cancer Center
Funded at Beckman Research Institute/city of Hope · NIH-10974180 · Data updated 2026-11-12
This study is looking for ways to create better treatments for Hodgkin lymphoma and non-Hodgkin lymphoma, and if you're a patient, you might have the chance to join exciting new trials that could help improve your care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beckman Research Institute/city of Hope NIH-funded |
| Lab location | 1 site (Duarte, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $208,103 |
| NIH project number | 1R50CA285409-01A1 |
| Project ID | NIH-10974180 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals diagnosed with Hodgkin lymphoma or non-Hodgkin lymphoma, particularly those who are seeking new treatment options.
✕Less likely to help
Patients with cancers other than Hodgkin lymphoma or non-Hodgkin lymphoma may not receive direct benefits from this research.
What this research studies
This research focuses on advancing clinical trials for Hodgkin lymphoma and non-Hodgkin lymphoma, led by Dr. Alex Herrera at the City of Hope Comprehensive Cancer Center. The project aims to develop novel therapies and improve treatment protocols through collaboration within the National Cancer Institute's clinical trials network. Patients may have the opportunity to participate in groundbreaking trials that could lead to more effective treatment options for their conditions.
Why it matters
Potential benefit: If successful, this research could provide patients with access to innovative therapies that significantly improve outcomes for Hodgkin lymphoma and related cancers.
How similar studies have gone: Previous research in similar clinical trial networks has shown success in developing effective treatments for various types of lymphoma, indicating a promising potential for this approach.
Where this research is happening
-
Beckman Research Institute/city of Hope
Duarte, United States Active
Researchers
- Principal investigator: Herrera, Alex F. — Beckman Research Institute/city of Hope
- Study coordinator: Herrera, Alex F.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.